• Fesgo

  Form: solution for injection

  Active substance	Dosage
  pertuzumab	600 mg
  trastuzumab	600 mg

  ATC: L01FY01

  Manufacturer: F. Hoffmann-La Roche Ltd

• Fesgo

  Form: solution for injection

  Active substance	Dosage
  pertuzumab	1200 mg
  trastuzumab	600 mg

  ATC: L01FY01

  Manufacturer: F. Hoffmann-La Roche Ltd

• Herceptin

  Form: lyophilisate for concentrate for infusion solution

  Active substance	Dosage
  trastuzumab	150 mg

  ATC: L01FD01

  Manufacturer: Genentech Inc. (Manufacturing of unpackaged products, primary packaging)

• Herceptin

  Form: lyophilisate for concentrate for infusion solution

  Active substance	Dosage
  trastuzumab	440 mg

  ATC: L01FD01

  Manufacturer: F. Hoffmann-La Roche Ltd (secondary packaging, quality control testing, batch release; solvent (production of unpackaged product, primary packaging, secondary packaging, quality control testing, batch release))

• Herceptin

  Form: solution for injection

  Active substance	Dosage
  trastuzumab	600 mg/5 ml

  ATC: L01FD01

  Manufacturer: F. Hoffmann-La Roche Ltd (manufacturing unpackaged products, packaging, quality control testing, batch release)

• Herzuma®

  Form: lyophilisate for concentrate for infusion solution

  Active substance	Dosage
  trastuzumab	150 mg

  ATC: L01FD01

  Manufacturer: PJSC Pharmaceutical Plant Egis (quality control, secondary packaging)

• Herzuma®

  Form: lyophilisate for concentrate for infusion solution

  Active substance	Dosage
  trastuzumab	440 mg

  ATC: L01FD01

  Manufacturer: PJSC Pharmaceutical Plant Egis (medicinal product: quality control, secondary packaging)

• Ontruzant

  Form: powder for concentrate for infusion solution

  Active substance	Dosage
  trastuzumab	150 mg

  ATC: L01FD01

  Manufacturer: Patheon Italia S.p.A. (manufacturing, primary packaging, quality control testing (sterility))

• Ontruzant

  Form: powder for concentrate for infusion solution

  Active substance	Dosage
  trastuzumab	420 mg

  ATC: L01FD01

  Manufacturer: Fareva Paull (Manufacturing, primary packaging; quality control testing (bacterial endotoxins and sterility))

• Zercepak

  Form: powder for concentrate for infusion solution

  Active substance	Dosage
  trastuzumab	150 mg

  ATC: L01FD01

  Manufacturer: Accord Healthcare Polska Sp. z o.o. Importer's Warehouse (Responsible for batch release)